A
$ Value
$0
Shares
176,000
Price
$0
Filed
Feb 5
Insider
Name
Bookman Michael
Title
CHIEF LEGAL OFFICER, SECRETARY
CIK
0001840339
Roles
Officer
Transaction Details
Transaction Date
2026-02-03
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
176,000
Footnotes
The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2026, and will be fully vested and exercisable on January 1, 2030.
Filing Info
Other Insiders at IMRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Matushansky Igor
Chief Medical Officer
|
— | — | 2026-02-03 |
|
Zeskind Benjamin J.
PRESIDENT AND CEO
|
— | — | 2026-02-03 |
|
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
|
— | — | 2026-02-03 |
|
Morales Mallory
SVP Finance, CAO
|
— | — | 2026-02-03 |
|
Neufeld Leah R
CHIEF PEOPLE OFFICER
|
— | — | 2026-02-03 |
|
Brakewood Harold Eugene
Chief Business Officer
|
— | — | 2026-02-03 |